{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# LMNA: CMD1A\n",
    "[Cardiomyopathy, dilated, 1A](https://omim.org/entry/115200) is caused by heterozygous variants in LMNA.\n",
    "\n",
    "Part of data in this template were derived from Table 1 of [Fatkin D, et al. (1999) Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341(23):1715-24. PMID:10580070](https://pubmed.ncbi.nlm.nih.gov/10580070/).\n",
    "\n",
    "\n",
    "Variants were curated as follows\n",
    "- Family A: Arg571Ser; C→A (1711): NM_005572.4(LMNA):c.1711C>A (p.Arg571Ser)\n",
    "- Family B: Asn195Lys; C→G (585): NM_170707.4(LMNA):c.585C>A (p.Asn195Lys) \n",
    "- Family C: Leu85Arg; T→G (254): NM_170707.4(LMNA):c.254T>G (p.Leu85Arg) \n",
    "- Family D: Arg60Gly; C→G (178): NM_170707.4(LMNA):c.178C>G (p.Arg60Gly)\n",
    "- Family E: Glu203Gly; A→G (608):  NM_170707.4(LMNA):c.608A>G (p.Glu203Gly)\n",
    "\n",
    "Note that in the MANE SELECT trasncript, NM_005572.4(LMNA):c.1711C>A (p.Arg571Ser) is equivalent to NM_170707.4:c.1698+13C>A. Therefore, in the Excel file, we use the transcript NM_005572.4. This will retrieve the correct genomic coordinates.\n",
    "\n",
    "The authors state that No family members with mutations had either joint contractures or skeletal myopathy. We therefore recorded the following terms  as excluded\n",
    "- Joint contracture (HP:0034392)\n",
    "- Muscle weakness (HP:0001324)\n",
    "- Skeletal muscle atrophy (HP:0003202)\n",
    "\n",
    "Additionally,  we will code the following two features as excluded (which are associated with other laminopathies but would certainly be ascertained by even a basic clinical examination)\n",
    "- Progeroid facial appearance HP:0005328 (see OMIM)\n",
    "- Lipodystrophy HP:0009125 (see OMIM)\n",
    "\n",
    "In [Sébillon et al (2003)](https://pubmed.ncbi.nlm.nih.gov/12920062/), the clinical data table indicates that some individuals had skeletal muscular dystrophy with mild weakness and muscle wasting. We exclude the skeletal muscle terms in the others and report weakness and atrophy in the individuals with dystrophy (including the indivudal reported to be borderline)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Using pyphetools version 0.9.113\n"
     ]
    }
   ],
   "source": [
    "from pyphetools.creation import TemplateImporter\n",
    "from pyphetools.visualization import IndividualTable, QcVisualizer\n",
    "from IPython.display import display, HTML\n",
    "import pyphetools\n",
    "print(f\"Using pyphetools version {pyphetools.__version__}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "HPO version 2024-08-13\n",
      "Created encoders for 50 fields\n",
      "Importing OMIM:115200, Cardiomyopathy, dilated, 1A, HGNC:6636, LMNA,  NM_005572.4\n",
      "We output 68 GA4GH phenopackets to the directory phenopackets\n"
     ]
    }
   ],
   "source": [
    "template = \"input/LMNA_CMD1A_individuals.xlsx\"\n",
    "created_by = \"0000-0002-0736-9199\"\n",
    "timporter = TemplateImporter(template=template,  created_by=created_by)\n",
    "individual_list, cvalidator = timporter.import_phenopackets_from_template()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<h2>Cohort validation</h2>\n",
       "<p>Errors found with 62 of 68 phenopackets.</p>\n",
       "<table style=\"border: 2px solid black; align: \"left\">\n",
       "<caption>Error counts</caption>\n",
       "<tr><th style=\"text-align: left;font-weight: bold;\">Level</th><th style=\"text-align: left;font-weight: bold;\">Error category</th><th style=\"text-align: left;font-weight: bold;\">Count</th></tr>\n",
       "<tr><td style=\"text-align: left;\">ERROR</td><td style=\"text-align: left;\">CONFLICT</td><td style=\"text-align: left;\">1</td></tr>\n",
       "<tr><td style=\"text-align: left;\">WARNING</td><td style=\"text-align: left;\">REDUNDANT</td><td style=\"text-align: left;\">86</td></tr>\n",
       "</table>\n",
       "<p>A total of 87 issues were fixed and no individual was removed from the cohort.</p>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "qc = QcVisualizer(cohort_validator=cvalidator)\n",
    "display(HTML(qc.to_summary_html()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table style=\"border: 2px solid black; align: \"left\">\n",
       "<caption>68 phenopackets - PMID:10580070 (n=39); PMID:12920062 (n=24); PMID:10662742 (n=5)</caption>\n",
       "<tr><th style=\"text-align: left;font-weight: bold;\">Individual</th><th style=\"text-align: left;font-weight: bold;\">Disease</th><th style=\"text-align: left;font-weight: bold;\">Genotype</th><th style=\"text-align: left;font-weight: bold;\">Phenotypic features</th></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A individual III-1 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1711C>A (heterozygous)</td><td style=\"text-align: left;\">Dilated cardiomyopathy (HP:0001644): onset ; Third degree atrioventricular block (HP:0001709): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A individual III-5 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1711C>A (heterozygous)</td><td style=\"text-align: left;\">excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A individual III-8  (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1711C>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Sinus bradycardia (HP:0001688): onset ; Thromboembolism (HP:0001907): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A individual III-9 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1711C>A (heterozygous)</td><td style=\"text-align: left;\">Congestive heart failure (HP:0001635): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Third degree atrioventricular block (HP:0001709): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A individual III-11 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1711C>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Second degree atrioventricular block (HP:0011706): onset ; Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A individual III-13 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1711C>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; First degree atrioventricular block (HP:0011705): onset ; Sinus bradycardia (HP:0001688): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A individual III-14 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1711C>A (heterozygous)</td><td style=\"text-align: left;\">First degree atrioventricular block (HP:0011705): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A individual III-15 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1711C>A (heterozygous)</td><td style=\"text-align: left;\">Atrioventricular block (HP:0001678): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual III-1 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.585C>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Congestive heart failure (HP:0001635): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Sudden cardiac death (HP:0001645): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual III-3 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.585C>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Sudden cardiac death (HP:0001645): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual III-11 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.585C>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Thromboembolic stroke (HP:0001727): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual III-13 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.585C>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Congestive heart failure (HP:0001635): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Sudden cardiac death (HP:0001645): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual IV-1 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.585C>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Congestive heart failure (HP:0001635): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Sudden cardiac death (HP:0001645): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual IV-4 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.585C>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual IV-8 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.585C>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Congestive heart failure (HP:0001635): onset ; Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual IV-10 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.585C>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual IV-16 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.585C>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Second degree atrioventricular block (HP:0011706): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual V-1 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.585C>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Sudden cardiac death (HP:0001645): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual V-2 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.585C>A (heterozygous)</td><td style=\"text-align: left;\">Sinus bradycardia (HP:0001688): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual II-1 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.254T>G (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual II-2 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.254T>G (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Sudden cardiac death (HP:0001645): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual II-4 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.254T>G (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Sudden cardiac death (HP:0001645): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual III-2 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.254T>G (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Congestive heart failure (HP:0001635): onset ; Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual III-4 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.254T>G (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Congestive heart failure (HP:0001635): onset ; Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family D individual II-1 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.178C>G (heterozygous)</td><td style=\"text-align: left;\">Congestive heart failure (HP:0001635): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Sudden cardiac death (HP:0001645): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family D individual II-4 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.178C>G (heterozygous)</td><td style=\"text-align: left;\">Sudden cardiac death (HP:0001645): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family D individual II-5 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.178C>G (heterozygous)</td><td style=\"text-align: left;\">excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family D individual III-2 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.178C>G (heterozygous)</td><td style=\"text-align: left;\">Congestive heart failure (HP:0001635): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Sinus bradycardia (HP:0001688): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family D individual III-3 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.178C>G (heterozygous)</td><td style=\"text-align: left;\">Congestive heart failure (HP:0001635): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Third degree atrioventricular block (HP:0001709): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family D individual III-6 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.178C>G (heterozygous)</td><td style=\"text-align: left;\">Dilated cardiomyopathy (HP:0001644): onset ; Atrioventricular block (HP:0001678): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family D individual III-7 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.178C>G (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family E individual II-2 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.608A>G (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Second degree atrioventricular block (HP:0011706): onset ; Thromboembolic stroke (HP:0001727): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family E individual II-4 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.608A>G (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Congestive heart failure (HP:0001635): onset ; Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family E individual II-6 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.608A>G (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Sudden cardiac death (HP:0001645): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family E individual II-8 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.608A>G (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Congestive heart failure (HP:0001635): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Second degree atrioventricular block (HP:0011706): onset ; Sudden cardiac death (HP:0001645): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family E individual II-9 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.608A>G (heterozygous)</td><td style=\"text-align: left;\">Congestive heart failure (HP:0001635): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Thromboembolic stroke (HP:0001727): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Atrioventricular block (HP:0001678): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family E individual III-1 (FEMALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.608A>G (heterozygous)</td><td style=\"text-align: left;\">First degree atrioventricular block (HP:0011705): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Elevated circulating creatine kinase concentration (HP:0003236): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family E individual III-4 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.608A>G (heterozygous)</td><td style=\"text-align: left;\">First degree atrioventricular block (HP:0011705): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family E individual III-8 (MALE)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.608A>G (heterozygous)</td><td style=\"text-align: left;\">First degree atrioventricular block (HP:0011705): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Sinus bradycardia (HP:0001688): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Thromboembolic stroke (HP:0001727): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A individual III.15 (FEMALE; P66Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.481G>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Left bundle branch block (HP:0011713): onset ; Increased left ventricular end-diastolic volume (HP:0033755): onset ; Severely reduced left ventricular ejection fraction (HP:0012666): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset <br/><b>TimeElement(element=Age(iso8601duration=P51Y))</b>: Congestive heart failure (HP:0001635): onset age {\n",
       "  iso8601duration: \"P51Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A individual III.16 (FEMALE; P53Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.481G>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Left bundle branch block (HP:0011713): onset ; Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A individual III.20 (FEMALE; P67Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.481G>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset <br/><b>TimeElement(element=Age(iso8601duration=P67Y))</b>: Thromboembolic stroke (HP:0001727): onset age {\n",
       "  iso8601duration: \"P67Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A individual IV.22 (MALE; P31Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.481G>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Premature ventricular contraction (HP:0006682): onset ; Thromboembolic stroke (HP:0001727): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A individual IV.28 (MALE; P45Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.481G>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset <br/><b>TimeElement(element=Age(iso8601duration=P34Y))</b>: Congestive heart failure (HP:0001635): onset age {\n",
       "  iso8601duration: \"P34Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A individual V.31 (FEMALE; P12Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.481G>A (heterozygous)</td><td style=\"text-align: left;\">excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family A individual V.32 (MALE; P16Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.481G>A (heterozygous)</td><td style=\"text-align: left;\">excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual III.7 (FEMALE; P55Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.28dup (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Second degree atrioventricular block (HP:0011706): onset ; Increased left ventricular end-diastolic volume (HP:0033755): onset ; Muscle weakness (HP:0001324): onset ; Skeletal muscle atrophy (HP:0003202): onset ; Severely reduced left ventricular ejection fraction (HP:0012666): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual III.5 (MALE; P47Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.28dup (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; First degree atrioventricular block (HP:0011705): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual III.12 (FEMALE; P44Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.28dup (heterozygous)</td><td style=\"text-align: left;\">First degree atrioventricular block (HP:0011705): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual IV.2 (FEMALE; P34Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.28dup (heterozygous)</td><td style=\"text-align: left;\">excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family B individual IV.3 (FEMALE; P35Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.28dup (heterozygous)</td><td style=\"text-align: left;\">Dilated cardiomyopathy (HP:0001644): onset ; Premature ventricular contraction (HP:0006682): onset ; Increased left ventricular end-diastolic volume (HP:0033755): onset ; Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual II.2 (FEMALE; P78Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1130G>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Left bundle branch block (HP:0011713): onset ; Muscle weakness (HP:0001324): onset ; Skeletal muscle atrophy (HP:0003202): onset ; Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset <br/><b>TimeElement(element=Age(iso8601duration=P78Y))</b>: Congestive heart failure (HP:0001635): onset age {\n",
       "  iso8601duration: \"P78Y\"\n",
       "}\n",
       "</td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual III.6 (FEMALE; P58Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1130G>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Third degree atrioventricular block (HP:0001709): onset ; Increased left ventricular end-diastolic volume (HP:0033755): onset ; Muscle weakness (HP:0001324): onset ; Skeletal muscle atrophy (HP:0003202): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual III.8 (MALE; P52Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1130G>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Left bundle branch block (HP:0011713): onset ; Ventricular tachycardia (HP:0004756): onset ; Increased left ventricular end-diastolic volume (HP:0033755): onset ; Muscle weakness (HP:0001324): onset ; Skeletal muscle atrophy (HP:0003202): onset ; Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual III.10 (MALE; P49Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1130G>A (heterozygous)</td><td style=\"text-align: left;\">First degree atrioventricular block (HP:0011705): onset ; Left bundle branch block (HP:0011713): onset ; Ventricular tachycardia (HP:0004756): onset ; Sudden cardiac death (HP:0001645): onset ; Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual III.12 (MALE; P51Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1130G>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; First degree atrioventricular block (HP:0011705): onset ; Sudden cardiac death (HP:0001645): onset ; Increased left ventricular end-diastolic volume (HP:0033755): onset ; Muscle weakness (HP:0001324): onset ; Skeletal muscle atrophy (HP:0003202): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual III.18 (MALE; P45Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1130G>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Left bundle branch block (HP:0011713): onset ; Ventricular tachycardia (HP:0004756): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual III.21 (FEMALE; P65Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1130G>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Atrioventricular block (HP:0001678): onset ; Increased left ventricular end-diastolic volume (HP:0033755): onset ; Muscle weakness (HP:0001324): onset ; Skeletal muscle atrophy (HP:0003202): onset ; Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual IV.8 (MALE; P27Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1130G>A (heterozygous)</td><td style=\"text-align: left;\">excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual IV.9 (FEMALE; P24Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1130G>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Ventricular tachycardia (HP:0004756): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual IV.10 (FEMALE; P21Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1130G>A (heterozygous)</td><td style=\"text-align: left;\">excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual IV.14 (FEMALE; P28Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1130G>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Severely reduced left ventricular ejection fraction (HP:0012666): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Family C individual IV.21 (MALE; P30Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.1130G>A (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Dilated cardiomyopathy (HP:0001644): onset ; excluded: First degree atrioventricular block (HP:0011705): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left bundle branch block (HP:0011713): onset ; excluded: Premature ventricular contraction (HP:0006682): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Individual II-1 (MALE; P22Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.960del (heterozygous)</td><td style=\"text-align: left;\">Congestive heart failure (HP:0001635): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Second degree atrioventricular block (HP:0011706): onset ; Third degree atrioventricular block (HP:0001709): onset ; Left bundle branch block (HP:0011713): onset ; Ventricular tachycardia (HP:0004756): onset ; Supraventricular tachycardia (HP:0004755): onset ; Increased left ventricular end-diastolic volume (HP:0033755): onset ; Muscle weakness (HP:0001324): onset ; Calf muscle hypertrophy (HP:0008981): onset ; Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; Increased circulating creatine kinase MM isoform (HP:0032234): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Left anterior fascicular block (HP:0011711): onset ; excluded: Premature atrial contractions (HP:0006699): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Spinal rigidity (HP:0003306): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Individual II-5 (MALE; P30Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.960del (heterozygous)</td><td style=\"text-align: left;\">Atrial fibrillation (HP:0005110): onset ; Congestive heart failure (HP:0001635): onset ; Dilated cardiomyopathy (HP:0001644): onset ; Second degree atrioventricular block (HP:0011706): onset ; Third degree atrioventricular block (HP:0001709): onset ; Left bundle branch block (HP:0011713): onset ; Ventricular tachycardia (HP:0004756): onset ; Sudden cardiac death (HP:0001645): onset ; Increased left ventricular end-diastolic volume (HP:0033755): onset ; Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Left anterior fascicular block (HP:0011711): onset ; excluded: Premature atrial contractions (HP:0006699): onset ; excluded: Supraventricular tachycardia (HP:0004755): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Calf muscle hypertrophy (HP:0008981): onset ; excluded: Spinal rigidity (HP:0003306): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset ; excluded: Increased circulating creatine kinase MM isoform (HP:0032234): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Individual III-1 (FEMALE; P4Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.960del (heterozygous)</td><td style=\"text-align: left;\">Dilated cardiomyopathy (HP:0001644): onset ; Premature atrial contractions (HP:0006699): onset ; Muscle weakness (HP:0001324): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left anterior fascicular block (HP:0011711): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Supraventricular tachycardia (HP:0004755): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Calf muscle hypertrophy (HP:0008981): onset ; excluded: Spinal rigidity (HP:0003306): onset ; excluded: Increased circulating creatine kinase MM isoform (HP:0032234): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Individual III-3 (MALE; P16Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.960del (heterozygous)</td><td style=\"text-align: left;\">Dilated cardiomyopathy (HP:0001644): onset ; Supraventricular tachycardia (HP:0004755): onset ; Muscle weakness (HP:0001324): onset ; Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; Increased circulating creatine kinase MM isoform (HP:0032234): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Left anterior fascicular block (HP:0011711): onset ; excluded: Premature atrial contractions (HP:0006699): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Calf muscle hypertrophy (HP:0008981): onset ; excluded: Spinal rigidity (HP:0003306): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset </td></tr>\n",
       "<tr><td style=\"text-align: left;\">Individual III-4 (FEMALE; P18Y)</td><td style=\"text-align: left;\">Cardiomyopathy, dilated, 1A (OMIM:115200)</td><td style=\"text-align: left;\">NM_005572.4:c.960del (heterozygous)</td><td style=\"text-align: left;\">Dilated cardiomyopathy (HP:0001644): onset ; Left anterior fascicular block (HP:0011711): onset ; Supraventricular tachycardia (HP:0004755): onset ; Spinal rigidity (HP:0003306): onset ; Increased circulating creatine kinase MM isoform (HP:0032234): onset ; excluded: Atrial fibrillation (HP:0005110): onset ; excluded: Congestive heart failure (HP:0001635): onset ; excluded: Second degree atrioventricular block (HP:0011706): onset ; excluded: Third degree atrioventricular block (HP:0001709): onset ; excluded: Premature atrial contractions (HP:0006699): onset ; excluded: Ventricular tachycardia (HP:0004756): onset ; excluded: Sudden cardiac death (HP:0001645): onset ; excluded: Increased left ventricular end-diastolic volume (HP:0033755): onset ; excluded: Progeroid facial appearance (HP:0005328): onset ; excluded: Lipodystrophy (HP:0009125): onset ; excluded: Joint contracture (HP:0034392): onset ; excluded: Muscle weakness (HP:0001324): onset ; excluded: Skeletal muscle atrophy (HP:0003202): onset ; excluded: Calf muscle hypertrophy (HP:0008981): onset ; excluded: Mildly reduced left ventricular ejection fraction (HP:0012663): onset ; excluded: Moderately reduced left ventricular ejection fraction (HP:0012665): onset </td></tr>\n",
       "</table>"
      ],
      "text/plain": [
       "<IPython.core.display.HTML object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "table = IndividualTable(cvalidator.get_error_free_individual_list())\n",
    "display(HTML(table.to_html()))"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "ps24venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
